etidronate has been researched along with Innate Inflammatory Response in 8 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Formation of heterotopic ossification (HO) in soft tissue after spinal cord injury (SCI) is associated with various degrees of inflammation." | 1.32 | C-reactive protein and erythrocyte sedimentation rate in patients with heterotopic ossification after spinal cord injury. ( Banovac, K; Estrores, IM; Harrington, A, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, MJ | 1 |
| Edwards, BS | 1 |
| Zhu, J | 1 |
| Sklar, LA | 1 |
| Graves, SW | 1 |
| Endo, Y | 2 |
| Funayama, H | 2 |
| Yamaguchi, K | 1 |
| Monma, Y | 2 |
| Yu, Z | 1 |
| Deng, X | 1 |
| Oizumi, T | 1 |
| Shikama, Y | 1 |
| Tanaka, Y | 1 |
| Okada, S | 1 |
| Kim, S | 1 |
| Kiyama, T | 1 |
| Bando, K | 1 |
| Shima, K | 1 |
| Suzuki, H | 1 |
| Takahashi, T | 1 |
| Luckish, A | 1 |
| Cernes, R | 1 |
| Boaz, M | 1 |
| Gavish, D | 1 |
| Matas, Z | 1 |
| Fux, A | 1 |
| Shargorodsky, M | 1 |
| Hemmati, I | 1 |
| Wade, J | 1 |
| Kelsall, J | 1 |
| Estrores, IM | 1 |
| Harrington, A | 1 |
| Banovac, K | 1 |
| Ohsako, M | 1 |
| Mayanagi, H | 1 |
| Sugawara, S | 1 |
| Carvalho, AP | 1 |
| Bezerra, MM | 1 |
| Girão, VC | 1 |
| Cunha, FQ | 1 |
| Rocha, FA | 1 |
| Creutzig, H | 1 |
2 reviews available for etidronate and Innate Inflammatory Response
| Article | Year |
|---|---|
[Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates].
Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Clini | 2020 |
Risedronate-associated scleritis: a case report and review of the literature.
Topics: Adrenal Cortex Hormones; Aged; Brain; China; Diphosphonates; Etidronic Acid; Female; Humans; Inflamm | 2012 |
1 trial available for etidronate and Innate Inflammatory Response
| Article | Year |
|---|---|
Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors.
Topics: Aged; Arteries; Biomarkers; Bone Density Conservation Agents; Cardiovascular Diseases; Compliance; D | 2008 |
5 other studies available for etidronate and Innate Inflammatory Response
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
C-reactive protein and erythrocyte sedimentation rate in patients with heterotopic ossification after spinal cord injury.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood Sedimentation; C-Reactive Protein; Etidronic A | 2004 |
Inhibition of inflammatory and bone-resorption-inhibitory effects of alendronate by etidronate.
Topics: Alendronate; Animals; Anti-Inflammatory Agents; Antimetabolites; Bone and Bones; Bone Resorption; Cl | 2005 |
Anti-inflammatory and anti-nociceptive activity of risedronate in experimental pain models in rats and mice.
Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Diphosphonates; | 2006 |
[Comparative investigations concerning osteotropic radiopharmaceuticals. III. Scanning with 18F and 99mTc-malignant diseases (author's transl)].
Topics: Abscess; Bone Diseases; Bone Neoplasms; Etidronic Acid; Female; Fluorine; Humans; Inflammation; Join | 1975 |